Back to results
US 10,881,663 B2Granted
Method of treating pain in elderly patients with mild renal impairment
AssigneeBaudax Bio, Inc.
InventorsRandall J. Mack, Stewart McCallum, Alexis Gomez, Alex Freyer
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to administration of meloxicam intravenously, for treatment of pain, in patients who are at least 65 years old and have mild renal impairment, which can provide fast onset of pain relief suitable for management of acute pain as well as moderate to severe pain.
Claims16
A method of treating pain, comprising administering to a patient in need thereof meloxicam intravenously at a dose of about 30 mg, wherein the patient is at least 65 years old and has mild renal impairment;
- wherein administration of meloxicam at the dose of about 30 mg is safe and well tolerated with no clinically meaningful differences between the patient and subjects aged 18 to 55 years with normal renal function (GFR>90 mL/min/1.73 m2), and the meloxicam is present as meloxicam nanocrystals.
Dependencies are inferred from the claim text.